Fresenius Medical Care | FME - Operating Expenses


Fresenius Medical Care reported EUR4.55B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Akzo Nobel EUR 2.61B 273M Sep/2026
Alcon AG USD 2.78B 370M Jun/2026
AstraZeneca USD 11.55B 674M Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Beiersdorf EUR 4.19B 32M Jun/2026
DaVita Healthcare Partners USD -591.09M 174.01M Sep/2026
Demant DKK 10.79B 1.16B Jun/2026
E.ON EUR 14.92B 186M Sep/2026
Essilor EUR 12.52B 568M Jun/2026
Fresenius EUR 5.24B 19M Sep/2026
Fresenius Medical Care EUR 4.55B 229.7M Sep/2026
Genmab DKK 748M 77M Jun/2026
Getinge SEK 7.03B 2.96B Jun/2026
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 6.03B 227M Sep/2026
GN Store Nord DKK 1.96B 156M Sep/2026
GRIFOLS EUR 1.65B 101M Sep/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.97B 630M Sep/2026
Novartis USD 9.88B 325M Sep/2026
Philips EUR 4.23B 478M Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
RWE EUR 6.44B 4.48B Sep/2026
Sanofi EUR 10.51B 598M Sep/2026
SAP EUR 9.34B 2.11B Sep/2026
Smith & Nephew USD 2.59B 71M Jun/2026